<DOC>
	<DOC>NCT00073515</DOC>
	<brief_summary>This trial is for patients with a central venous catheter (a vascular access device) that is not functioning properly (unable to withdraw blood). The trial compares a new blood clot dissolving agent (alfimeprase) against the currently used treatment.</brief_summary>
	<brief_title>Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular Access Devices</brief_title>
	<detailed_description />
	<criteria>Subjects must: have a dysfunctional Central Venous Access Device (CVAD) defined as unable to withdraw 3 mL blood have had the device in place for &gt; 48 hours be clinically stable be 18 or older give informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2005</verification_date>
	<keyword>central venous access device</keyword>
	<keyword>thrombosis</keyword>
	<keyword>central venous catheter</keyword>
	<keyword>thrombolysis</keyword>
	<keyword>fibrinolysis</keyword>
</DOC>